Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | increases expression | ISO | Cd37 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of CD37 mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | multiple interactions | ISO | Cd37 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of CD37 mRNA | CTD | PMID:22206623 | 17alpha-ethynylestradiol | affects expression | ISO | Cd37 (Mus musculus) | 6480464 | Ethinyl Estradiol affects the expression of CD37 mRNA | CTD | PMID:17555576 | 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of CD37 mRNA | CTD | PMID:15834898 and PMID:17351261 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Cd37 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of CD37 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of CD37 mRNA | CTD | PMID:34747641 | 2,6-di-tert-butyl-4-methylphenol | decreases expression | ISO | Cd37 (Mus musculus) | 6480464 | Butylated Hydroxytoluene results in decreased expression of CD37 mRNA | CTD | PMID:19925653 | 2-butoxyethanol | decreases expression | ISO | Cd37 (Mus musculus) | 6480464 | n-butoxyethanol results in decreased expression of CD37 mRNA | CTD | PMID:19812364 | 3,4-methylenedioxymethamphetamine | increases expression | ISO | Cd37 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of CD37 mRNA | CTD | PMID:26251327 | 4,4'-diaminodiphenylmethane | increases expression | EXP | | 6480464 | 4 and 4'-diaminodiphenylmethane results in increased expression of CD37 mRNA | CTD | PMID:30723492 | 4-hydroxyphenyl retinamide | decreases expression | ISO | Cd37 (Mus musculus) | 6480464 | Fenretinide results in decreased expression of CD37 mRNA | CTD | PMID:28973697 | 9-cis-retinoic acid | increases expression | EXP | | 6480464 | Alitretinoin results in increased expression of CD37 mRNA | CTD | PMID:16648578 | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of CD37 mRNA | CTD | PMID:31881176 | all-trans-retinoic acid | decreases expression | ISO | Cd37 (Mus musculus) | 6480464 | Tretinoin results in decreased expression of CD37 mRNA | CTD | PMID:16604517 | all-trans-retinoic acid | increases expression | ISO | CD37 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of CD37 mRNA | CTD | PMID:33167477 | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of CD37 mRNA | CTD | PMID:16483693 | antirheumatic drug | decreases expression | ISO | CD37 (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of CD37 mRNA | CTD | PMID:24449571 | aristolochic acid A | increases expression | ISO | CD37 (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of CD37 mRNA | CTD | PMID:33212167 | arsane | decreases methylation | ISO | CD37 (Homo sapiens) | 6480464 | Arsenic results in decreased methylation of CD37 gene | CTD | PMID:31135185 | arsenic atom | decreases methylation | ISO | CD37 (Homo sapiens) | 6480464 | Arsenic results in decreased methylation of CD37 gene | CTD | PMID:31135185 | atrazine | decreases expression | EXP | | 6480464 | Atrazine results in decreased expression of CD37 mRNA | CTD | PMID:36841081 | benzo[a]pyrene | decreases expression | ISO | Cd37 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of CD37 mRNA | CTD | PMID:21569818 | benzo[a]pyrene | decreases methylation | ISO | CD37 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of CD37 exon and Benzo(a)pyrene results in decreased methylation of CD37 promoter | CTD | PMID:27901495 | benzo[a]pyrene | increases methylation | ISO | CD37 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of CD37 3' UTR | CTD | PMID:27901495 | benzo[a]pyrene | multiple interactions | ISO | Cd37 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CD37 mRNA | CTD | PMID:27858113 | benzo[b]fluoranthene | multiple interactions | ISO | Cd37 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CD37 mRNA | CTD | PMID:27858113 | bexarotene | increases expression | EXP | | 6480464 | bexarotene results in increased expression of CD37 mRNA | CTD | PMID:16648578 | bis(2-ethylhexyl) phthalate | decreases expression | ISO | CD37 (Homo sapiens) | 6480464 | Diethylhexyl Phthalate results in decreased expression of CD37 mRNA | CTD | PMID:31163220 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of CD37 mRNA | CTD | PMID:25181051 more ... | bisphenol A | increases expression | ISO | Cd37 (Mus musculus) | 6480464 | bisphenol A results in increased expression of CD37 mRNA | CTD | PMID:32156529 | buta-1,3-diene | decreases expression | ISO | Cd37 (Mus musculus) | 6480464 | 1 and 3-butadiene results in decreased expression of CD37 mRNA | CTD | PMID:29038090 | carbon nanotube | increases expression | ISO | Cd37 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | chloroprene | decreases expression | ISO | Cd37 (Mus musculus) | 6480464 | Chloroprene results in decreased expression of CD37 mRNA | CTD | PMID:23125180 | choline | multiple interactions | ISO | Cd37 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CD37 mRNA and [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CD37 gene | CTD | PMID:20938992 | chrysene | multiple interactions | ISO | Cd37 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CD37 mRNA | CTD | PMID:27858113 | cisplatin | decreases expression | ISO | CD37 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of CD37 mRNA | CTD | PMID:27392435 | copper atom | decreases expression | EXP | | 6480464 | Copper results in decreased expression of CD37 mRNA | CTD | PMID:30556269 | copper(0) | decreases expression | EXP | | 6480464 | Copper results in decreased expression of CD37 mRNA | CTD | PMID:30556269 | copper(II) sulfate | decreases expression | ISO | CD37 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of CD37 mRNA | CTD | PMID:19549813 | Cuprizon | increases expression | EXP | | 6480464 | Cuprizone results in increased expression of CD37 mRNA | CTD | PMID:27523638 | dichloromethane | decreases expression | EXP | | 6480464 | Methylene Chloride results in decreased expression of CD37 mRNA | CTD | PMID:20955722 | dimethylarsinic acid | multiple interactions | ISO | Cd37 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD37 mRNA | CTD | PMID:34876320 | diuron | decreases expression | ISO | CD37 (Homo sapiens) | 6480464 | Diuron results in decreased expression of CD37 mRNA | CTD | PMID:35967413 | ethylbenzene | decreases expression | EXP | | 6480464 | ethylbenzene results in decreased expression of CD37 mRNA | CTD | PMID:20955722 | flavonoids | increases expression | EXP | | 6480464 | Flavonoids results in increased expression of CD37 mRNA | CTD | PMID:18035473 | folic acid | multiple interactions | ISO | Cd37 (Mus musculus) | 6480464 | [1 more ... | CTD | PMID:20938992 and PMID:22206623 | folic acid | increases expression | ISO | Cd37 (Mus musculus) | 6480464 | Folic Acid results in increased expression of CD37 mRNA | CTD | PMID:25629700 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of CD37 mRNA | CTD | PMID:22061828 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of CD37 mRNA | CTD | PMID:33387578 | glycidol | increases expression | EXP | | 6480464 | glycidol results in increased expression of CD37 mRNA | CTD | PMID:24915197 | hexachlorobenzene | decreases expression | EXP | | 6480464 | Hexachlorobenzene results in decreased expression of CD37 mRNA | CTD | PMID:15159207 | isotretinoin | increases expression | ISO | CD37 (Homo sapiens) | 6480464 | Isotretinoin results in increased expression of CD37 mRNA | CTD | PMID:20436886 | L-methionine | multiple interactions | ISO | Cd37 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CD37 mRNA and [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CD37 gene | CTD | PMID:20938992 | lead(0) | decreases expression | ISO | CD37 (Homo sapiens) | 6480464 | Lead results in decreased expression of CD37 mRNA | CTD | PMID:19921347 | methotrexate | affects expression | ISO | Cd37 (Mus musculus) | 6480464 | Methotrexate affects the expression of CD37 mRNA | CTD | PMID:18502557 | methylarsonic acid | multiple interactions | ISO | Cd37 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD37 mRNA | CTD | PMID:34876320 | N-nitrosodiethylamine | multiple interactions | ISO | Cd37 (Mus musculus) | 6480464 | [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of CD37 gene | CTD | PMID:23968726 | nickel atom | increases expression | ISO | CD37 (Homo sapiens) | 6480464 | Nickel results in increased expression of CD37 mRNA | CTD | PMID:24768652 and PMID:25583101 | ozone | decreases expression | ISO | Cd37 (Mus musculus) | 6480464 | Ozone results in decreased expression of CD37 mRNA | CTD | PMID:12763052 | ozone | multiple interactions | ISO | Cd37 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of CD37 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of CD37 mRNA | CTD | PMID:34911549 | paracetamol | increases expression | ISO | CD37 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of CD37 mRNA | CTD | PMID:26690555 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of CD37 mRNA | CTD | PMID:33387578 | paracetamol | decreases expression | ISO | CD37 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of CD37 mRNA | CTD | PMID:22230336 | piperonyl butoxide | multiple interactions | ISO | Cd37 (Mus musculus) | 6480464 | [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of CD37 gene | CTD | PMID:23968726 | prothioconazole | decreases expression | ISO | CD37 (Homo sapiens) | 6480464 | prothioconazole results in decreased expression of CD37 mRNA | CTD | PMID:35048155 | silicon dioxide | decreases expression | ISO | Cd37 (Mus musculus) | 6480464 | Silicon Dioxide results in decreased expression of CD37 mRNA | CTD | PMID:19073995 | sodium arsenate | multiple interactions | ISO | Cd37 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD37 mRNA | CTD | PMID:34876320 | sodium arsenite | multiple interactions | ISO | Cd37 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD37 mRNA | CTD | PMID:34876320 | sodium arsenite | increases expression | ISO | Cd37 (Mus musculus) | 6480464 | sodium arsenite results in increased expression of CD37 mRNA | CTD | PMID:36209798 | tamoxifen | affects expression | ISO | Cd37 (Mus musculus) | 6480464 | Tamoxifen affects the expression of CD37 mRNA | CTD | PMID:17555576 | Tesaglitazar | increases expression | EXP | | 6480464 | tesaglitazar results in increased expression of CD37 mRNA | CTD | PMID:21515302 | testosterone | decreases expression | ISO | CD37 (Homo sapiens) | 6480464 | Testosterone results in decreased expression of CD37 mRNA | CTD | PMID:33359661 | tetraphene | multiple interactions | ISO | Cd37 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CD37 mRNA | CTD | PMID:27858113 | trichloroethene | decreases expression | EXP | | 6480464 | Trichloroethylene results in decreased expression of CD37 mRNA | CTD | PMID:20955722 and PMID:33387578 | triptonide | increases expression | ISO | Cd37 (Mus musculus) | 6480464 | triptonide results in increased expression of CD37 mRNA | CTD | PMID:33045310 | troglitazone | increases expression | ISO | Cd37 (Mus musculus) | 6480464 | troglitazone results in increased expression of CD37 mRNA | CTD | PMID:28973697 | troglitazone | increases expression | EXP | | 6480464 | troglitazone results in increased expression of CD37 mRNA | CTD | PMID:21515302 | valproic acid | increases methylation | ISO | CD37 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of CD37 gene | CTD | PMID:29154799 | vinclozolin | increases expression | EXP | | 6480464 | vinclozolin results in increased expression of CD37 mRNA | CTD | PMID:23034163 | |